Blue Owl Capital Inc. (NYSE: OWL) reported that Dyal Capital SLP LP filed a code J transaction involving 350,000 shares. Dyal held 131,414,357 shares after the transaction, which represented about 0.3% of its prior shareholding. The transaction was reported on September 11, 2026. Following …
BONK, INC. (NASDAQ: BNKK) will purchase 26,667 Series A preferred shares from Core4 Capital for $4,000,000 under an agreement dated September 4, 2026. The purchase is paired with Core4’s irrevocableWaiverof anti-dilution protections and rights under the Series A Certificate of Designation. Payment is due …
BBB FOODS INC (NYSE: TBBB) insider Reich Sapire Rose Nicole Dominique sold 7,623 shares at $51 per share on September 9, 2026. The transaction left the insider with no shares held after completion.
BC Partners Lending Corporation secured approval from approximately 84.6% of voting shareholders for its merger with Alternative Credit Income Fund. The transaction would make ACIF a wholly owned subsidiary of BCPL through the planned merger steps.
BEASLEY BROADCAST GROUP INC (NASDAQ: BBGI) CAO Greening Shaun Peter sold 378 shares at $15.78 per share. The transaction took his reported holding to 0 shares.
BillionToOne, Inc. (NASDAQ: BLLN) executive ten Bosch John Roderick sold 1,416 shares at $97.54 per share. The transaction involved the company’s SVP of Laboratory Operations and took place on September 9, 2026. Ten Bosch John Roderick is identified as BillionToOne’s SVP of Laboratory Operations. …
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) has registered the resale of up to 170,150 ordinary shares by selling shareholders. The ordinary shares are represented by 3,403 American Depositary Shares, making the transaction a shareholder resale rather than an issuer-led sale. The prospectus supplement is dated …
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) is registering the resale of up to 10,950 ordinary shares represented by 219 American Depositary Shares by selling shareholders. The securities are covered by a prospectus supplement dated September 11, 2026. The stated transaction is a resale by selling …
BioStem Technologies, Inc. (NASDAQ: BSEM) Chief Commercial Officer Hassett Barry exercised options for 500 shares at $0 per share on Sep 9, 2026. The same transaction covered 500 derivative securities.
Athena Technology Acquisition Corp. II (OTC: ATEK) shareholders approved the proposedMergerwith Ace Green Recycling Inc. by 9,835,040 votes for, with zero votes against, abstentions or broker non-votes.